top of page

FDA Gives Green Light for Multiple Sclerosis Stem Cell Trial

SUGAR LAND, Texas--(BUSINESS WIRE)--Non-profit research organization Hope Biosciences Stem Cell Research Foundation (HBSCRF) has received FDA authorization for a randomized, double-blind, single center, Phase II clinical trial to assess the efficacy of multiple intravenous infusions of autologous adipose-derived mesenchymal stem cells in improving symptoms and quality of life in patients with mild-to-moderate multiple sclerosis (MS). Read more →

Recent Posts

See All

Meet the designer behind Christina Greene Jewelry

Many Houstonians might know Houston designer Christina Greene for her striking combination of gold and turquoise jewelry. What they might not know is that she credits the Houston Livestock Show and Ro

Comments


bottom of page